4//SEC Filing
Pelossof Avi 4
Accession 0000950142-17-001793
CIK 0001145460other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 5:39 PM ET
Size
33.8 KB
Accession
0000950142-17-001793
Insider Transaction Report
Form 4
ALERE INC.ALR
Pelossof Avi
Pres., Infectious Disease
Transactions
- Disposition to Issuer
Common Stock
2017-10-03−26,005→ 0 total - Disposition to Issuer
Employee Stock Option (Right to Buy)
2017-10-03−2,500→ 0 totalExercise: $18.91→ Common Stock (2,500 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2017-10-03−14,081→ 0 totalExercise: $35.58→ Common Stock (14,081 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2017-10-03−5,000→ 0 totalExercise: $38.64→ Common Stock (5,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2017-10-03−20,000→ 0 totalExercise: $26.06→ Common Stock (20,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2017-10-03−50,000→ 0 totalExercise: $19.20→ Common Stock (50,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2017-10-03−5,000→ 0 totalExercise: $36.74→ Common Stock (5,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2017-10-03−10,000→ 0 totalExercise: $19.15→ Common Stock (10,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2017-10-03−5,000→ 0 totalExercise: $38.01→ Common Stock (5,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2017-10-03−1,125→ 0 totalExercise: $25.43→ Common Stock (1,125 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2017-10-03−25,000→ 0 totalExercise: $33.73→ Common Stock (25,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2017-10-03−45,000→ 0 totalExercise: $45.47→ Common Stock (45,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2017-10-03−14,250→ 0 totalExercise: $25.68→ Common Stock (14,250 underlying) - Disposition to Issuer
Restricted Stock Units
2017-10-03−19,470→ 0 total→ Common Stock (19,470 underlying)
Footnotes (3)
- [F1]Pursuant to that certain Agreement and Plan of Merger, dated as of January 30, 2016, as amended on April 13, 2017 (the "Merger Agreement"), between Alere Inc. (the "Company") and Abbott Laboratories, at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock (the "Common Stock") was converted into the right to receive $51.00 (the "Merger Consideration").
- [F2]Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option.
- [F3]Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Pursuant to the Merger Agreement, at the Effective Time, each outstanding Restricted Stock Unit was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time and (ii) the Merger Consideration.
Documents
Issuer
ALERE INC.
CIK 0001145460
Entity typeother
Related Parties
1- filerCIK 0001293460
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 5:39 PM ET
- Size
- 33.8 KB